% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ochsnerbier ochsnerbier Jan 15, 2013 1:49 PM Flag

    Funds adding to their positions


    The same thing happened last January when the stock price got up to $9.98, but the rest of the year sucked. Did you see the 8K relating to compensation they filed on 14 Jan. I find it egregious. Gorman gets a bonus of $220K, four other "chiefs" get bonuses ranging from $109K to $151K. Gormans base salary will be $541K, the four other "chiefs" base salaries range from $321K to $445K. Gorman was granted 175K options, the others were granted 75K to 86K. The pigs were definitely at the trough. By every measure IMO it was a terrible year. VMAT compromised PII trial. Urocortin 2 shelved. No new compounds came out of the lab when Gorman on at least two occasions said there would be compounds coming out. Stock price was flat to down for the year and shareholders were diluted. There is more but you get the picture.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I sold some traders @$8.66 and still have some shares to go.

      Almost pulled the trigger today since the stock is above $9

      Last years run up was in front of that botched VMAT2 trial.

      The market still has some upside but its starting to get oversold.


49.54+0.60(+1.23%)Aug 26 4:00 PMEDT